Christie Edward M III 4
4 · Encompass Health Corp · Filed Jul 16, 2026
Research Summary
AI-generated summary of this filing
Encompass Health (EHC) Director Christie Edward M III Receives RSUs
What Happened
Christie Edward M III, a non-employee director of Encompass Health Corporation (EHC), received awards/acquisitions totaling 259 shares in mid‑July 2026. On July 15, 2026 he was credited 11 restricted stock units (RSUs) in connection with the company’s $0.19/share dividend (reported at $0.00 per share). On July 16, 2026 he acquired 248 shares at a reported weighted average price of $112.43 per share (total value reported $27,883). These transactions are awards/acquisitions (code A) rather than sales.
Key Details
- Transaction dates and amounts:
- 2026-07-15: 11 RSUs credited (dividend-related), $0.00 per share reported.
- 2026-07-16: 248 shares acquired at a weighted avg price $112.43; total reported = $27,883. Purchases occurred at prices ranging $112.40–$112.43 (per footnote).
- Shares owned after transaction: Not reported in this filing.
- Notable footnotes:
- F1: 11 RSUs credited under outstanding RSU award agreements in connection with the $0.19 dividend (dividend amount / closing price calculation).
- F2: 248 shares were purchased by the company’s Directors Deferred Stock Investment Plan using fee deferrals and reinvested dividends.
- F3: Reported per‑share price is a weighted average; purchases spanned $112.40–$112.43.
- Filing timeliness: Form 4 filed 2026-07-16 for transactions on 2026-07-15 and 2026-07-16 — appears timely (no late filing flag).
Context
- These transactions reflect director compensation and deferral-plan activity (dividend crediting of RSUs and plan-funded share purchases), not an open‑market sale by the director.
- Transaction code "A" denotes an award/acquisition (RSUs/purchases); there was no exercise or sale reported here.
- The 248-share purchase represents modest insider buying (~$27.9k) via the company plan rather than a direct market order by the director.
Insider Transaction Report
Form 4
Christie Edward M III
Director
Transactions
- Award
Encompass Health Common Stock
[F1]2026-07-15+11→ 9,097 total - Award
Encompass Health Common Stock
[F2][F3]2026-07-16$112.43/sh+248$27,883→ 9,345 total
Footnotes (3)
- [F1]Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.
- [F2]The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2025 to defer fixed percentages of their director fees for 2026. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the director's fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly fee deferral and the dividend of $0.19 per share paid on July 15, 2026.
- [F3]This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $112.40 to $112.43, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Signature
/s/Patrick Darby, attorney-in-fact for Edward M. Christie, III|2026-07-16